|
|
Mission
-
To
provide high quality patient care within a patient-centered interdisciplinary
clinical environment based on compassion, clinical excellence and the
integration of cutting edge research.
-
To
serve as a national and international center for clinical and basic science
research with an emphasis on bringing the current research finding into
clinical practice.
-
To
provide a comprehensive education program which will train neuromuscular
specialist for careers in academic medicine and clinical research.
-
To
serve as a resource center for patients seeking information about neuromuscular
diseases.
-
To
work collaboratively with federal/state/local government agencies and
other non-profit organizations to develop venues for funding clinical
services and research.
Clinical
Centers
-
Muscular
Dystrophy Clinic
-
-
Peripheral
Neuropathy Clinic
-
Autonomic/EMG
Laboratories
Clinical
Trials
-
Translational
Research In dystrophinopathies
-
Gentamicin
Treatment in Duchenne Muscular Dystrophy
-
Long-term
Safety and Tolerability Study in Patients with Amyotrophic Lateral Sclerosis
-
Strength
Testing in Neuromuscular Patients
-
Clinical
Trial of Albuterol and Oxandrolone in Facioscapulohumeral Dystrophy
-
A
Randomized Double Blind Placebo Controlled Stratified Parallel Group
Multi-Dose Study In Evaluating Four Oral Doses of TCH346 in Amyotrophic
Lateral Sclerosis
-
Clinical
Trial of Diltiazem In Facioscapulohumeral Dystrophy
-
A
Trial of Mycophenolate Mofetil In Myasthenia Gravis
-
A
Trial of Insulin Like Growth Factor in Amyotrophic Lateral Sclerosis.
Contact
OSU Department of Neurology
Division of Neuromuscular Diseases
461 Means Hall
1654 Upham Drive
Columbus, Ohio 43210
Phone: 614-293-4981
Fax: 614-293-6111
|
|
